Company: TIPT
Filing Date: 2025-10-17
Form Type: PREM14A
Source: 0001140361-25-038514
Chunk: 140

Company: TIPTREE INC.
Filing Date: 2025-10-17
Form: PREM14A
Chunk 140
---
 Expense Amount; and |

| • | each share of Fortegra preferred stock issued and outstanding immediately prior to the Effective Time will be converted into and thereafter evidence the right to receive in cash the Series A Liquidation Preference. |

Each Fortegra share issued and outstanding immediately prior to the Effective Time, when converted or cancelled in accordance with the above two bullets, will no longer be outstanding, will automatically be cancelled and will cease to exist. At the Effective Time, each Fortegra share that is owned by Fortegra or any of the Subsidiaries will automatically be cancelled and retired and will cease to exist, and no consideration will be delivered in exchange therefor. Treatment of Fortegra’s Equity Awards Prior to the Effective Time, the Fortegra Board (or, if appropriate, any committee thereof administering the Fortegra Equity Plan) will adopt resolutions or take such other actions as may be required to cause each Fortegra stock option and each Fortegra RSU award, in each case, that is outstanding and unvested immediately prior to the Effective Time, whether or not then subject to any performance or other condition, to accelerate and vest at the Effective Time, with the performance conditions applicable to the Fortegra stock options deemed achieved as determined by Fortegra. At the Effective Time, each such vested Fortegra RSU award will, by virtue of the Merger, be cancelled, and in full consideration of such cancellation, will be converted into and thereafter evidence the right to receive, without

71

#### TABLE OF CONTENTS
interest and less applicable tax withholding, an amount in cash equal to (i)(A) the Per Share Closing Merger Consideration multiplied by (B) the number of Fortegra shares subject to such vested Fortegra RSU award plus (ii) the Leakage Delayed Consideration attributable to such Fortegra shares (if any), and minus (iii) in the case of each of the Minority Investors, such holder’s Pro Rata Percentage of the Equityholders’ Representative Expense Amount, attributable to such Fortegra shares.

From and after the Effective Time, each dollar-denominated performance-based award that represents the right to acquire shares of Fortegra common stock granted under the Fortegra Equity Plan and that is outstanding immediately prior to the Effective Time pursuant to its terms (each, a “Fortegra performance award”), will continue in effect in accordance with its existing terms and conditions (except as expressly provided in the Merger Agreement), subject to any adjustments necessary to preserve the value of such Fortegra performance award, as measured immediately prior to the